drugset / Trial / NCT01436292
Hypoalbuminemia in Burn Patients
Phase 4
Withdrawn
University of Montreal Hospital Centre (CHUM)
Centre de Recherche du Centre Hospitalier de l'Université de Montréal · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether 5% human albumin solution, given to correct hypoalbuminemia, could improve organ dysfunction in burn patients as assessed by a change in the SOFA score from baseline to day 7 (or before if the patient is discharged from the ICU or died).
Timeline
- Start
- 2011-09
- Primary completion
- 2015-09
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albumin | Protein / enzyme biologic | 25 g | — |
| Subject | Albumin | Protein / enzyme biologic | 50 g | — |
| Subject | Albumin | Protein / enzyme biologic | 75 g | — |
| Subject | Albumin | Protein / enzyme biologic | 100 g | — |
| Subject | Albumin | Protein / enzyme biologic | 150 g | — |
Indications
No indication recorded.